Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis.

Background: Expenditure on systemic therapy for cancer has been increasing quickly owing to population growth, increased use, both in the number of users and in prescription volume, and rising drug prices. Our objective was to describe trends in expenditure in British Columbia and Saskatchewan's cancer care systems and to elucidate these drivers of growth.

Methods: In this trend analysis, we obtained pharmacy dispensing records from the BC Cancer and Saskatchewan Cancer Agency pharmacies for all anticancer therapies dispensed in 2006-2013.

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Study Objective: To test a brief intervention for preventing statin nonadherence among community pharmacy patrons.

Design: Prospective, cluster-randomized, controlled trial (the Community Pharmacists Assisting in Total Cardiovascular Health [CPATCH] trial).

Setting: Thirty community pharmacies in Saskatchewan, Canada.

Adherence to imatinib among patients attending Saskatchewan Cancer Agency Pharmacies.

Rationale: Chronic use of imatinib confers an important survival benefit for individuals with chronic myeloid leukemia. In Saskatchewan, the provincial cancer agency addresses important barriers to adherence by providing imatinib at no cost through specialized cancer centers.

Objective: To describe adherence to imatinib dispensed through the Saskatchewan Cancer Agency.